SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-030481
Filing Date
2024-03-04
Accepted
2024-03-04 16:09:36
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 tm247713-1_s3.htm S-3 549772
2 EXHIBIT 4.3 tm247713d2_ex4-3.htm EX-4.3 37721
3 EXHIBIT 4.4 tm247713d2_ex4-4.htm EX-4.4 274225
4 EXHIBIT 5.1 tm247713d2_ex5-1.htm EX-5.1 30942
5 EXHIBIT 23.1 tm247713d2_ex23-1.htm EX-23.1 2452
6 EX-FILING FEES tm247713d2_ex-filingfees.htm EX-FILING FEES 56375
7 GRAPHIC tm247713d2_ex5-1img002.jpg GRAPHIC 24036
8 GRAPHIC lg_passage-4c.jpg GRAPHIC 26232
  Complete submission text file 0001104659-24-030481.txt   1022119
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-277632 | Film No.: 24715043
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)